Movement Alert|Moderna, Inc. Pre-Market Rise 3.55%, Trading at 153.82 USD

Market Focus09-04 19:27

On September 4, Moderna, Inc. rose 3.55% in pre-market trading, trading at 153.82 USD/share, with Turnover of 18.54 million USD.

Within the Biotechnology sector where Moderna, Inc. belongs, among individual stocks, Amgen down 0.54%, AbbVie down 0.08%, Gilead Sciences down 0.05%, Alnylam Pharmaceuticals up 0.19%, Hyperliquid Strategies Inc down 0.39%.

Moderna, Inc. is a leader in messenger RNA (mRNA) medicine. Its mRNA platform has enabled the development of therapeutics and vaccines across infectious diseases, immuno-oncology, rare diseases, and autoimmune diseases. The company has strategic collaborations with Merck, AstraZeneca, Vertex Pharmaceuticals, and others.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment